Cullen/Frost Bankers, Inc. Eli Lilly & CO Transaction History

Cullen/Frost Bankers, Inc.

$6.83 Billion
Q2 2024

A detailed history of Cullen/Frost Bankers, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 102,851 shares of LLY stock, worth $93.5 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

102,851

Previous 104,237 1.33%

Holding current value

$93.5 Million

Previous $81.1 Million 14.83%

% of portfolio

1.36%

Previous 1.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$724.87 - $909.04 $1 Million - $1.26 Million	-1,386 Reduced 1.33%	102,851 $93.1 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $2.49 Million - $3.33 Million	-4,204 Reduced 3.88%	104,237 $81.1 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $4.01 Million - $4.73 Million	-7,638 Reduced 6.58%	108,441 $63.2 Million
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $869,834 - $1.2 Million	-2,001 Reduced 1.69%	116,079 $62.3 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $953,311 - $1.27 Million	-2,718 Reduced 2.25%	118,080 $55.4 Million
Q1 2023 May 05, 2023	SELL	$310.63 - $364.82 $80,453 - $94,488	-259 Reduced 0.21%	120,798 $41.5 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $2.64 Million - $3.07 Million	8,205 Added 7.27%	121,057 $44.3 Million
Q3 2022 Nov 07, 2022	BUY	$296.48 - $337.87 $1.07 Million - $1.22 Million	3,624 Added 3.32%	112,852 $36.5 Million
Q2 2022 Aug 05, 2022	BUY	$278.73 - $327.27 $747,275 - $877,410	2,681 Added 2.52%	109,228 $35.4 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $611,367 - $759,774	2,605 Added 2.51%	106,547 $30.5 Million
Q4 2021 Feb 07, 2022	SELL	$224.85 - $279.04 $681,295 - $845,491	-3,030 Reduced 2.83%	103,942 $28.7 Million
Q3 2021 Nov 04, 2021	BUY	$221.6 - $272.71 $1.01 Million - $1.25 Million	4,571 Added 4.46%	106,972 $24.7 Million
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $658,285 - $851,486	-3,646 Reduced 3.44%	102,401 $23.5 Million
Q1 2021 May 05, 2021	BUY	$164.32 - $212.72 $26,455 - $34,247	161 Added 0.15%	106,047 $19.8 Million
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $818,897 - $1.08 Million	6,277 Added 6.3%	105,886 $17.9 Million
Q3 2020 Nov 05, 2020	BUY	$146.22 - $169.13 $11.1 Million - $12.9 Million	76,092 Added 323.56%	99,609 $14.7 Million
Q2 2020 Aug 05, 2020	SELL	$136.42 - $164.18 $53,613 - $64,522	-393 Reduced 1.64%	23,517 $3.86 Million
Q1 2020 May 01, 2020	SELL	$119.05 - $147.35 $114,407 - $141,603	-961 Reduced 3.86%	23,910 $3.32 Million
Q4 2019 Feb 06, 2020	SELL	$106.92 - $132.43 $128,838 - $159,578	-1,205 Reduced 4.62%	24,871 $3.27 Million
Q3 2019 Nov 01, 2019	SELL	$106.79 - $116.16 $178,339 - $193,987	-1,670 Reduced 6.02%	26,076 $2.92 Million
Q2 2019 Aug 01, 2019	SELL	$110.79 - $129.32 $80,765 - $94,274	-729 Reduced 2.56%	27,746 $3.07 Million
Q1 2019 Apr 30, 2019	SELL	$111.31 - $131.02 $339,050 - $399,086	-3,046 Reduced 9.66%	28,475 $3.7 Million
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $835,551 - $936,069	7,890 Added 33.39%	31,521 $3.65 Million
Q3 2018 Oct 29, 2018	SELL	$85.86 - $107.31 $130,850 - $163,540	-1,524 Reduced 6.06%	23,631 $2.54 Million
Q2 2018 Jul 27, 2018	SELL	$75.7 - $86.88 $80,771 - $92,700	-1,067 Reduced 4.07%	25,155 $2.15 Million
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $315,021 - $371,862	-4,245 Reduced 13.93%	26,222 $2.03 Million
Q4 2017 Jan 31, 2018	SELL	$81.94 - $87.89 $37,856 - $40,605	-462 Reduced 1.49%	30,467 $2.57 Million
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $2.38 Million - $2.65 Million	30,929	30,929 $2.65 Million

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Eli Lilly & CO Transaction History